Images |
Sources |
Experiment + Assay |
Phenotypes |
Human Diseases |
|
Fig. 3. CDEF
Wang F et al. (2015)
|
Xla Wt + ptf1a gRNA2 CRISPR
NF43 (in situ hybridization)
|
|
|
|
Fig.3 KN
Wang F et al. (2015)
|
Xla Wt + ptf1a gRNA2/3 CRISPR
NF43 (in situ hybridization)
|
|
|
|
Fig. 3 LMOP
Wang F et al. (2015)
|
Xla Wt + ptf1a gRNA2/3 CRISPR
NF43 (in situ hybridization)
|
|
|
|
Fig. 3. GHIJ
Wang F et al. (2015)
|
Xla Wt + ptf1a gRNA3 CRISPR
NF43 (in situ hybridization)
|
|
|
|
Fig.1 AC
Wang F et al. (2015)
|
Xtr Wt + ptf1a CRISPR
NF43 (in situ hybridization)
|
|
|
|
C, D
Hanotel J et al. (2014)
|
Xla Wt + ptf1a
neurula stage (in situ hybridization)
|
|
|
|
A
Hanotel J et al. (2014)
|
Xla Wt + ptf1a
neurula stage (in situ hybridization)
|
|
|
|
B
Hanotel J et al. (2014)
|
Xla Wt + ptf1a
neurula stage (in situ hybridization)
|
|
|
|
C, D
Hanotel J et al. (2014)
|
Xla Wt + ptf1a + rbpj
neurula stage (in situ hybridization)
|
|
|
|
M
Hanotel J et al. (2014)
|
Xla Wt + ptf1a MO
neurula stage (in situ hybridization)
|
|
|